A recent ruling by the Upper Tribunal in Illuminate Skin Clinics Ltd v HMRC [2025] UKUT 00341 (TCC) has sharpened the legal focus on a key VAT issue: under what circumstances do aesthetic treatments qualify as medical care? The case centred on whether services like Botox, dermal fillers, and fat-reduction injections — provided by a qualified doctor — could be exempt from VAT under UK law.
The Tribunal’s decision underscores a critical distinction: it’s not enough for a treatment to be delivered by a medical professional. For VAT exemption to apply, the service must have a therapeutic purpose — diagnosing, treating, or preventing a disease or health disorder. Under UK law, services consisting in the provision of medical care by a registered practitioner may be exempt from VAT. This case provides important judicial guidance on how tribunals should assess whether aesthetic treatments qualify as medical care for VAT purposes — a development that may influence how clinics approach documentation and service classification.
The Core Issue
Dr Sophie Shotter, a qualified doctor and founder of Illuminate Skin Clinics (Illuminate), provided treatments ranging from Botox and dermal fillers to fat-reduction injections. Illuminate applied for VAT repayment on the basis that these services were exempt rather than taxable. HMRC refused the claim, and the First-tier Tribunal (FTT) agreed with HMRC, concluding that the services did not constitute medical care. Illuminate appealed to the Upper Tribunal.
The Four Grounds for Appeal
Illuminate appealed on four grounds. Here’s how the Upper Tribunal addressed each:
Ground 1: Wrong Legal Test Applied
Illuminate argued the FTT wrongly used a “principal purpose” test instead of asking whether the services were “purely cosmetic.”
Upper Tribunal Decision: Rejected. The Tribunal held that identifying the principal purpose is the correct legal test when determining whether a supply qualifies as medical care.
Ground 2: Misapplication of Purpose Test
Illuminate claimed the FTT failed to distinguish between therapeutic and cosmetic purposes and did not properly engage with their argument.
Upper Tribunal Decision: Rejected. The Tribunal found the FTT had correctly focused on whether the therapeutic purpose was the principal purpose and had applied the law appropriately.
Ground 3: Overly Narrow Interpretation of Medical Care
Illuminate argued the FTT confined its assessment too narrowly, especially regarding diagnosis and therapeutic aim.
Upper Tribunal Decision: Allowed. The Tribunal found the FTT erred by placing no weight on consultation records that evidenced medical diagnoses and by setting too high a standard for what constitutes a diagnosis.
Ground 4: Failure to Address Legislative Intent
Illuminate contended that HMRC and the FTT effectively imposed conditions not present in UK legislation, contrary to Article 131 of the VAT Directive.
Upper Tribunal Decision: Rejected. The Tribunal held that the FTT had not imposed any unlawful conditions and had correctly applied the exemption criteria.
Decision – Case Remitted to the First-tier Tribunal
The Upper Tribunal concluded that the FTT failed to properly consider whether specific treatments had a principal therapeutic purpose — particularly where diagnoses were made — the Upper Tribunal set aside the original decision and remitted the case back to the FTT for reconsideration. The FTT is now expected to apply a multi-factorial analysis to individual treatments, considering factors such as diagnosis, symptoms, practitioner intent, and patient understanding.
What This Means for Clinics
This ruling offers valuable guidance for aesthetic and wellness providers. Documentation is critical — clinics may need to demonstrate a medical rationale, not just aesthetic goals. Purpose defines tax status — even medically administered treatments can be taxable if their primary aim is cosmetic. And regulatory alignment isn’t enough — being CQC-registered or medically qualified doesn’t automatically confer VAT exemption.
While the Upper Tribunal has clarified the legal framework, the case has now been remitted to the First-tier Tribunal for reconsideration. Clinics and advisors should watch closely for the outcome, as it may further shape how individual treatments are assessed and what evidence is considered sufficient to support VAT exemption.
How Xeinadin Can Help
Navigating the VAT landscape in aesthetic medicine is complex — and increasingly high-stakes. The Xeinadin VAT team has expertise in healthcare and wellness sector taxation, and we’re here to help you assess whether your services qualify for VAT exemption, review and strengthen your clinical documentation, prepare for HMRC scrutiny, and structure your operations to optimise VAT treatment. Whether you’re a clinic owner, practitioner, or advisor, we’re ready to support you.
To start the conversation, contact the Xeinadin Indirect Tax team at [email protected].
